(Q46143058)

19 December 2017

title

Vaccination with mannan protects mice against systemic aspergillosis (English)

1 reference

19 December 2017

0 references

Min Liu

1

1 reference

19 December 2017

Eva Machová

2

1 reference

19 December 2017

Zuzana Neščáková

3

1 reference

19 December 2017

Izabela Medovarská

4

1 reference

19 December 2017

Karl V Clemons

5

1 reference

19 December 2017

Marife Martinez

6

1 reference

19 December 2017

Vicky Chen

7

1 reference

19 December 2017

Slavomir Bystrický

8

1 reference

19 December 2017

David A Stevens

9

1 reference

19 December 2017

publication date

15 May 2012

1 reference

19 December 2017

published in

Medical Mycology

1 reference

19 December 2017

volume

50

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

818-828

1 reference

19 December 2017

Vaccinate against aspergillosis! A call to arms of the immune system.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Developing a vaccine against aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Saccharomyces as a vaccine against systemic aspergillosis: 'the friend of man' a friend again?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Saccharomyces cerevisiae as a vaccine against coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Candida albicans mannan-protein conjugate as vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Polysaccharide-protein conjugates: a new generation of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Colorimetric Method for Determination of Sugars and Related Substances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Worst-rank score analysis with informatively missing observations in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Problems in dealing with missing data and informative censoring in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Conformational differences among mono- and oligosaccharide fragments of O-specific polysaccharides of Vibrio cholerae O1 revealed by circular dichroism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

The macrophage mannose receptor induces IL-17 in response to Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Fungal β-Glucans and Mammalian Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Defining criteria for anti-mannan antibodies to protect against candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

Efficacy of oral saperconazole in systemic murine aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.683539

10.3109/13693786.2012.683539

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

release_veqvv2lze5abzphpb3oreslnfq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/veqvv2lze5abzphpb3oreslnfq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 December 2017